Literature DB >> 16354468

Epidemiological study of patients with connective tissue diseases in Brazil.

Maria Do Socorro Teixeira Moreira Almeida1, Manoel Barros Bértolo, Benedito Borges Da Silva, Antônio De Deus Filho, Mayra Moreira Almeida, Fabíola Ferreira Hortêncio Veras, Luciano Cardoso Mendes.   

Abstract

To study the prevalence of connective tissue disorders and identify the epidemiological profile of the population from the northern and northeastern regions of Brazil. All patients admitted to the general medical ward at Getulio Vargas Hospital were screened through history and physical examination for the existence of known, suspected or possible connective tissue disorder. A total of 120 patients were enrolled in the study - 61 (50.8%) with systemic lupus erythematosus (SLE), 41 (34.2%) with rheumatoid arthritis (RA), 16 (13.3%) with systemic sclerosis (SS), one (0.8%) with mixed connective tissue disease (MCTD) and one (0.8%) with polymyositis (PM). Women accounted for (104) 86.7% of the participants and (83) 70.9% were non-Caucasians. The mean age was 36.8 years. Alopecia was the most frequent symptom (55/46.6%), followed by other cutaneous lesions (50/42.4%), dyspnea (47/39.8%) and chest pain (39/33.0%). The most frequent rheumatologic disorder encountered in our hospital-based study population was systemic lupus erythematosus, which is contrary to findings of the majority of studies performed in this country.

Entities:  

Mesh:

Year:  2005        PMID: 16354468     DOI: 10.1258/004947505774938602

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  1 in total

1.  Differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein.

Authors:  Wenhui Li; Hui Li; Wuqi Song; Yunlong Hu; Yanhong Liu; Rong DA; Xiaobei Chen; Yang Li; Hong Ling; Zhaohua Zhong; Fengmin Zhang
Journal:  Exp Ther Med       Date:  2013-09-17       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.